Silva, Juliane Maria dos Santos and Almeida, Jackson Roberto Guedes da Silva and Alves, Cristiane dos Santos Cerqueira and Nery, Daniel Amando and Damasceno, Livia Maria Oliveira and Araújo, Camila de Souza and Rolim, Larissa Araújo and Oliveira, Ana Paula de (2020) Antimicrobial Activity from Species Plectranthus amboinicus (Lour.) Spreng, a Review. European Journal of Medicinal Plants, 31 (18). pp. 1-14. ISSN 2231-0894
974-Article Text-1923-1-10-20221012.pdf - Published Version
Download (416kB)
Abstract
Introduction: Nowadays, several bacteria have acquired resistance to available antimicrobial agents making necessary the search for new therapeutic alternatives. Plectranthus amboinicus L. is a succulent and aromatic herb, popularly known as thick leaf mint, used in popular medicine for the treatment of colds, digestive diseases, asthma, headache and to fight pathogenic bacteria activity. In view the antimicrobial activity of P. amboinicus this study had as aim to review publications involving researches about antimicrobial activity of this species.
Materials and Methods: For this, PubMed, Scopus, Science Direct and Scielo databases were consulted in November 2020 using the keywords Plectranthus amboinicus and antimicrobial activity. In vitro and/or in vivo studies on the antimicrobial activity of the species in the last 10 years were considered.
Results: The main microorganisms evaluated were: Klebsiella pneumoniae, Mycobacterium tuberculosis, Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, and some Candida species. The essential oils had carvacrol, germacrene D, thymol and camphor as main constituents. Most studies evaluated the antimicrobial activity using broth dilution and agar diffusion methods. In most studies essential oil, extracts and/or isolated substances showed significant antimicrobial activity. Synergistic activity was also observed through association with antibiotics.
Conclusion: P. amboinicus has therapeutic potential for antimicrobial treatments and can be an alternative to the treatment of resistant microorganisms and that further in vivo and clinical studies with the species are still needed.
Item Type: | Article |
---|---|
Subjects: | Scholar Eprints > Medical Science |
Depositing User: | Managing Editor |
Date Deposited: | 21 Feb 2023 06:20 |
Last Modified: | 07 Nov 2024 10:12 |
URI: | http://repository.stmscientificarchives.com/id/eprint/1303 |